General form of registration statement for all companies including face-amount certificate companies

SHARE-BASED COMPENSATION

v3.21.2
SHARE-BASED COMPENSATION
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
SHARE-BASED COMPENSATION

13. SHARE-BASED COMPENSATION

Stock Options

The following table summarizes the Company’s stock option activity since December 31, 2020:

 

Stock
Options

 

Weighted-Average Exercise
Price

 

Weighted-Average Remaining Contractual Term (Years)

 

Aggregate Intrinsic
Value

Balance as at December 31, 2020

 

896,888

 

 

$

5.22

 

3.96

 

$

2,889

Granted

 

60,079

 

 

$

13.92

 

9.70

 

 

Exercised

 

(40,942

)

 

$

0.24

 

 

$

434

Forfeited

 

(27,857

)

 

$

12.11

 

 

 

Expired

 

(85,399

)

 

$

8.40

 

 

 

Balance as at June 30, 2021

 

802,769

 

 

$

5.96

 

3.97

 

$

3,361

Vested and expected to vest as at
June 30, 2021

 

791,488

 

 

$

5.90

 

4.09

 

$

3,364

Vested and exercisable as at
June 30, 2021

 

413,241

 

 

$

6.23

 

3.77

 

$

1,702

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common shares for all stock options that had exercise prices lower than the fair value of the Company’s common shares.

The weighted-average grant-date fair value per share of share-based awards granted during the six months ended June 30, 2021 was $10.11.

Restricted Share Units

Time-based Restricted Share Units

The fair value for time-based RSUs is based on the closing price of the Company’s common shares on the grant date.

The following table summarizes the changes in the Company’s time-based restricted share unit activity during the three months ended June 30, 2021:

 

Restricted
Share
Units

 

Weighted-
Average
Grant Date
Fair Value

Unvested as of December 31, 2020

 

78,634

 

 

$

3.25

Granted

 

365,300

 

 

 

14.04

Vested

 

(12,824

)

 

 

8.66

Canceled/forfeited

 

(6,219

)

 

 

13.89

Unvested as of June 30, 2021

 

424,891

 

 

$

12.28

Market-based Restricted Share Units

During the six months ended June 30, 2021, the Company granted RSUs with both a market condition and a service condition (market-based RSUs) to the Company’s employees. The market-based condition for these awards requires that the Company’s common shares maintain a closing price equal to or greater than $12.50 or $15.00 per share for any 20 trading days within any consecutive 30 trading day period on or before December 18, 2022 or December 18, 2024, respectively. Provided that the market-based condition is satisfied, and the respective employee remains employed by the Company, the market-based restricted share units will vest in four equal annual installments on the applicable vesting date.

The following table presents the weighted-average assumptions used in the Monte Carlo simulation model to determine the fair value of the market-based restricted share units granted in the six months ended June 30, 2021:

 

Six Months Ended
June 30, 2021

Grant date share price

 

$

14.40

 

Risk-free interest rate

 

 

0.5

%

Expected dividend yield

 

 

0.0

%

Expected volatility

 

 

90

%

Expected life (in years)

 

 

1.8–3.8

 

The following table summarizes the changes in the Company’s market-based restricted share unit activity during the six months ended June 30, 2021:

 

Restricted Share
Units

 

Weighted-Average Grant Date Fair
Value

Unvested as of December 31, 2020

 

 

 

$

Granted

 

1,038,718

 

 

 

13.89

Canceled/forfeited

 

(20,666

)

 

 

4.02

Unvested as of June 30, 2021

 

1,018,052

 

 

$

13.89

No market-based RSUs vested during the six months ended June 30, 2021.

Please refer to Note 16 for RSUs granted subsequent to June 30, 2021.

Share-Based Compensation Expense

The following table summarizes the Company’s recognized share-based compensation expense for each of its awards for the periods presented:

 

Six Months Ended

 

Three Months Ended

   

June 30,
2021

 

June 30,
2020

 

June 30,
2021

 

June 30,
2020

Share-based compensation award type Stock Options

 

721

 

713

 

365

 

297

RSUs

 

4,152

 

 

2,958

 

Total Shared Based Compensation
Expense

 

4,873

 

713

 

3,323

 

297

The Company recognized share-based compensation expense in general and administrative expense in its Condensed Consolidated Statements of Operations.

15. SHARE-BASED COMPENSATION

Northern Swan Holdings, Inc. 2018 Omnibus Incentive Compensation Plan

The Northern Swan Holdings, Inc. 2018 Omnibus Incentive Compensation Plan, as amended (the “2018 Plan”) provides for the Company to grant incentive stock options, nonqualified stock options, restricted share units (“RSUs”) and other stock-based awards to its employees, directors, officers, outside advisors and non-employee consultants.

As of December 31, 2020, the Company has reserved 4,500,000 common shares for issuance to its employees, directors, outside advisors and non-employee consultants pursuant to the 2018 Plan. Unless otherwise provided, at the time of grant, the options issued pursuant to the 2018 Plan expire ten years from the date of grant and generally vest over four years, with 25% of the award vesting in four equal installments. As of December 31, 2020, no new awards will be issued under the 2018 Plan.

Clever Leaves Holdings Inc. 2020 Incentive Award Plan

In connection with the Business Combination, the Company adopted the Clever Leaves Holdings Inc. 2020 Incentive Award Plan (the “2020 Plan”) which provides for the Company to grant incentive stock options, nonqualified stock options, restricted share units and other shares-based awards to its employees, directors, officers, outside advisors and non-employee consultants.

As of December 31, 2020, the Company has reserved 2,813,215 common shares for issuance to its employees, directors, outside advisors and non-employee consultants pursuant to the 2020 Plan. Unless otherwise provided, at the time of grant, the options issued pursuant to the 2020 Plan generally expire ten years from the date of grant and generally vest over four years, with 25% of the award vesting in four equal installments. As of December 31, 2020 and December 31, 2019, 2,813,215 and nil shares, respectively, were available for future grants of the Company’s common shares under the 2020 Plan.

Clever Leaves Holdings Inc. 2020 Earnout Award Plan

In connection with the Business Combination, the Company adopted the Clever Leaves Holdings Inc. 2020 Earnout Award Plan (the “Earnout Plan”). The purpose of the Earnout Plan is to provide equity awards following the Closing Date to certain directors, employees and consultants that have contributed to the Business Combination. Under the Earnout Plan, (i) shares constituting 50% of the share reserve will be issued only if the closing price of the Company’s common shares on Nasdaq equals or exceeds $12.50 per share (as adjusted for shares splits, reverse splits, stock dividends, reorganizations, recapitalizations or any similar event) for any 20 trading days within any consecutive 30 trading day period on or before the second anniversary of the Closing, and (ii) shares constituting the remaining 50% of the share reserve will be issued only if the closing price of the Company’s common shares on Nasdaq equals or exceeds $15.00 per share (as adjusted for stock splits, reverse splits, stock dividends, reorganizations, recapitalizations or any similar event) for any 20 trading days within any consecutive 30 trading day period on or before the fourth anniversary of the Closing. Equity awards granted prior to these hurdles being met will vest only if the applicable hurdles are achieved; equity awards granted following the hurdles being achieved need not include the hurdles. In addition, the Company’s board of directors may choose to impose additional vesting conditions. As of December 31, 2020 and December 31, 2019, 1,440,000 and no shares, respectively, were available for future grants of the Company’s common shares under the Earnout Plan. As of December 31, 2020, no shares have been granted under the Earnout Plan.

The 2018 Plan, 2020 Plan, and Earnout Plan are administered by the Company’s board of directors or, at the discretion of the Company’s board of directors, by a committee thereof. The exercise prices, vesting and other restrictions are determined at the discretion of the Company’s board of directors, or its committee if so delegated. The Company’s board of directors values the Company’s common shares, taking into consideration the most recently available valuation thereof performed by third parties, as well as additional factors which may have changed since the date of the most recent contemporaneous valuation through the date of grant.

Stock Option Valuation

The following table presents the weighted-average assumptions used in the Black-Scholes-Merton option pricing model to determine the fair value of stock options and RSUs granted during periods presented:

 

Year Ended

   

December 31, 2020

 

December 31, 2019

Expected term

 

0.14 – 5.00    

 

2.79 – 5.00

 

Risk-free interest rate

 

0.22 – 0.41%

 

1.3 – 2.7

%

Expected dividend yield

 

0.0%

 

0.0

%

Expected volatility

 

85% – 90%

 

80

%

Stock Options

The following table summarizes the Company’s stock option activity since December 31, 2019:

 

Stock
Options

 

Weighted-Average Exercise
Price

 

Weighted-Average Remaining Contractual Term (Years)

 

Aggregate Intrinsic Value

Balance as at December 31, 2019

 

1,195,544

 

 

$

14.18

 

3.21

 

$

3,194

Granted

 

121,291

 

 

$

6.71

 

3.64

 

 

 

Exercised

 

(88,706

)

 

$

0.24

 

 

$

705

Forfeited

 

(331,241

)

 

$

11.86

 

 

 

 

Balance as at December 31, 2020

 

896,888

 

 

$

5.22

 

3.96

 

$

2,889

Vested and expected to vest as at December 31, 2020

 

885,607

 

 

$

5.60

 

3.97

 

$

2,906

Vested and exercisable as at December 31, 2020

 

419,498

 

 

$

6.80

 

3.78

 

$

944

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common shares for all stock options that had exercise prices lower than the fair value of the Company’s common shares.

The weighted-average grant-date fair value per share of stock options granted during the year ended December 31, 2020 and 2019 was $2.02 and $2.64, respectively.

Restricted Share Units

The following table summarizes the Company’s restricted share unit activity since December 31, 2019:

 

Restricted
Share Units

 

Weighted-Average
Grant Date
Fair Value

Unvested as of December 31, 2019

 

 

 

$

Granted

 

83,715

 

 

 

3.25

Vested

 

(2,989

)

 

 

3.25

Canceled/forfeited

 

(2,092

)

 

 

3.25

Unvested as of December 31, 2020

 

78,634

 

 

$

3.25

The total fair value of restricted share units vested during the year ended December 31, 2020 and 2019 was $51 and $nil, respectively.

Share-Based Compensation Expense

During the year ended December 31, 2020 and 2019, the Company recognized share-based compensation expense related to its stock options of $1,366 and $1,522, respectively, in general and administrative expense in the consolidated statement of operations. The stock-based compensation expense related to unvested stock option awards not yet recognized as of December 31, 2020 and 2019 was $2,276 and $4,477, respectively, which is expected to be recognized over a weighted-average period of 1.9 years and 2.7 years, respectively.

During the year ended December 31, 2020 and 2019, the Company recognized share-based compensation expense related to its restricted share units of $286 and $nil, respectively, in general and administrative expense in the

consolidated statement of operations. The total compensation cost related to unvested restricted share unit awards not yet recognized as of December 31, 2020 and 2019 was $521 and $nil, respectively, which is expected to be recognized over a weighted-average period of 1.3 years and 0.0 years, respectively.

The Company recognized total share-based compensation expense of $1,652 and $1,522 for the year ended December 31, 2020 and 2019, respectively, in general and administrative expense in the consolidated statement of operations. Share-based compensation costs were not tax deductible for the periods presented.